BioSpace News Archive

Ionis Pharmaceuticals, Inc., the leader in antisense therapeutics, announced that management will present a company overview at the following investor conferences:

Allurion Technologies Announces Submission of US Premarket Approval (PMA) Application for its Flagship Elipse ® Gastric Balloon Submission paves way for the company’s procedureless™ weight loss device to enter the US Company also names Joyce Johnson as Vice President, Regulatory Affairs and Quality Assurance

Phase I dose escalation completed for BT1718 — RP2D established and preliminary signs of anti-tumor activity observed, including one partial response - Dosing complete in second cohort of Phase I dose escalation for BT5528 — all doses administered in Phase I to date appear tolerable - Significant achievements in multiple partnered programs beyond oncology - Progress across pipeline continues despite uncertainties associated with coronav

Telemedicine collaboration expands comprehensive NURTEC ODT patient affordability and access programs

Clinical chatbot Gia offers new tools for OB/GYNs, oncologists, genetic counselors and other clinicians who order genetic testing

Rallybio LLC, a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders, announced the hiring of Michael Greco, JD to lead the Company’s legal function.

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that the Canadian Patent Office has indicated its intent to grant the Company a patent for its invention titled “Methods and Compositions for Oral Administration of Proteins.”

Presentation highlighted the potential of the company’s lead candidate, the anti-SEMA4D antibody pepinemab, to regulate glial cell activation and neurodegeneration in Alzheimer’s and Huntington’s disease

Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that its Bioflux® units are designed for QT interval analysis, a section of the ECG, to identify serious risks like QT prolongation

Coronavirus is the type of virus that belongs to either of the two subfamilies, Coronavirinae or Torovirinae and it generally affects the respiratory tract of mammals.